{"entity":{"id":"da-eisai","kind":"company","name":"Eisai","aka":[],"tldr":"Eisai is a medicines company that co-developed lecanemab.","summary":"Listed as the lecanemab sponsor partner on this atlas. Company pages here are map nodes, not investment advice.","asOf":"2026-09-21","links":[{"label":"Eisai","url":"https://www.eisai.com/"}],"tags":["dementia-atlas"],"related":[],"cancers":[],"sections":[],"technologies":[],"targets":[],"drugs":["da-lecanemab"],"companies":[],"institutions":[],"pathways":[],"terms":[],"trials":["da-trial-clarity-ad"],"people":[],"bottlenecks":[],"keyPapers":[],"journals":[],"dependsOn":[],"notes":[],"hq":"Tokyo","country":"JP","companyType":"pharma","website":"https://www.eisai.com/","investors":[],"funding":[]},"route":"/companies/da-eisai/","neighbours":{"drug":[{"id":"da-lecanemab","kind":"drug","name":"Lecanemab","route":"/drugs/da-lecanemab/"}],"trial":[{"id":"da-trial-clarity-ad","kind":"trial","name":"CLARITY AD","route":"/trials/da-trial-clarity-ad/"}],"cancer":[{"id":"alzheimers-disease","kind":"cancer","name":"Alzheimer’s disease","route":"/diagnoses/alzheimers-disease/"}]}}